Department of Surgery, James P. Wilmot Cancer Institute, University of Rochester Medical Center, 265 Crittenden Blvd., Box CU 420658, Rochester, NY, 14642, USA.
Department of Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Box 704, Rochester, NY, 14642, USA.
Curr Oncol Rep. 2018 Feb 1;20(1):5. doi: 10.1007/s11912-018-0657-2.
To (1) explain what yoga is, (2) summarize published literature on the efficacy of yoga for managing cancer treatment-related toxicities, (3) provide clinical recommendations on the use of yoga for oncology professionals, and (4) suggest promising areas for future research.
Based on a total of 24 phase II and one phase III clinical trials, low-intensity forms of yoga, specifically gentle hatha and restorative, are feasible, safe, and effective for treating sleep disruption, cancer-related fatigue, cognitive impairment, psychosocial distress, and musculoskeletal symptoms in cancer patients receiving chemotherapy and radiation and cancer survivors. Clinicians should consider prescribing yoga for their patients suffering with these toxicities by referring them to qualified yoga professionals. More definitive phase III clinical trials are needed to confirm these findings and to investigate other types, doses, and delivery modes of yoga for treating cancer-related toxicities in patients and survivors.
（1）解释瑜伽是什么，（2）总结瑜伽在缓解癌症治疗相关毒性方面的有效性的文献，（3）为肿瘤专业人员使用瑜伽提供临床建议，（4）为未来研究提出有前景的领域。
基于总共 24 项 2 期和 1 项 3 期临床试验，低强度形式的瑜伽，特别是温和哈他和恢复性瑜伽，对于治疗接受化疗和放疗的癌症患者以及癌症幸存者的睡眠障碍、癌症相关疲劳、认知障碍、心理社会困扰和肌肉骨骼症状是可行、安全和有效的。临床医生应该考虑通过将患者转介给合格的瑜伽专业人员，为患有这些毒性的患者开具瑜伽处方。需要更明确的 3 期临床试验来证实这些发现，并研究其他类型、剂量和瑜伽的提供方式，以治疗患者和幸存者的癌症相关毒性。
